Loading…
Nirman Agri Genetics (NIRMAN)₹26.25+1.55%Other Agricultural Products
In the Mar 2026 quarter (standalone), Nirman Agri Genetics reported sales of ₹49.93 Cr, down 59.7% from Mar 2025, and net profit of ₹2.99 Cr, down 78.6% year on year. For the year to Mar 2026, sales were ₹197 Cr and net profit ₹17.96 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 13.99 | 23.97 | 38.98 | 112 | 124 | 146 | 49.93 |
| Expenses | 10.97 | 19.95 | 32.95 | 99.87 | 110 | 131 | 46.91 |
| Operating Profit | 3.01 | 4.01 | 7.01 | 12.01 | 15.01 | 15.02 | 4.01 |
| OPM % | 20.0% | 19.0% | 17.0% | 11.0% | 12.0% | 10.0% | 7.0% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 0.00 | 0.00 |
| Profit before tax | 2.99 | 3.99 | 6.97 | 11.95 | 13.94 | 14.94 | 2.99 |
| Tax % | 10.0% | 10.0% | 2.0% | 4.0% | 3.0% | 3.0% | 3.0% |
| Net Profit | 1.99 | 3.99 | 5.99 | 10.98 | 13.98 | 14.98 | 2.99 |
| EPS (Rs) | 2.97 | 4.92 | 8.12 | 14.34 | 17.08 | 18.26 | 3.79 |
| Mar 2021 8m | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales | 3.99 | 12.99 | 28.97 | 62.97 | 237 | 197 |
| Expenses | 3.99 | 9.97 | 23.94 | 51.91 | 210 | 178 |
| Operating Profit | 0.00 | 3.01 | 4.01 | 11.01 | 27.01 | 19.01 |
| OPM % | 1.8% | 25.0% | 15.0% | 18.0% | 11.0% | 10.0% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 1.01 |
| Profit before tax | 0.00 | 2.99 | 3.99 | 10.95 | 25.89 | 17.93 |
| Tax % | 29.0% | 25.0% | 6.0% | 5.0% | 3.0% | 3.0% |
| Net Profit | 0.00 | 2.99 | 3.99 | 9.99 | 24.96 | 17.96 |
| EPS (Rs) | — | — | 5.02 | 13.03 | 31.64 | 22.06 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 0.02 | 0.02 | 5.99 | 6.00 | 7.99 | 8.00 |
| Reserves | 0.00 | 3.01 | 21.02 | 31.06 | 102 | 120 |
| Borrowings | 0.99 | 0.99 | 0.99 | 0.99 | 0.00 | 0.00 |
| Other Liabilities | 0.99 | 2.00 | 1.99 | 5.97 | 2.99 | 1.99 |
| Total Liabilities | 1.99 | 6.01 | 29.99 | 44.02 | 113 | 129 |
| Fixed Assets | 0.00 | 0.00 | 1.01 | 0.00 | 2.01 | 2.01 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 1.99 | 6.01 | 28.98 | 44.02 | 111 | 128 |
| Inventories | 0.00 | 1.01 | 5.01 | 8.02 | 37.08 | 47.06 |
| Trade receivables | 1.01 | 4.01 | 4.01 | 12.02 | 38.09 | 70.14 |
| Cash & equivalents | 1.01 | 0.99 | 0.00 | 2.01 | 25.99 | 0.99 |
| Total Assets | 1.99 | 6.01 | 29.99 | 44.02 | 113 | 129 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from operating activity | 0.00 | — | 0.00 | 3.98 | −31.90 | −23.90 |
| Cash from investing activity | 0.00 | — | −21.06 | −2.01 | 10.03 | 0.00 |
| Cash from financing activity | 1.01 | — | 20.05 | −1.01 | 46.17 | −1.01 |
| Net cash flow | 1.01 | — | −1.01 | 1.01 | 24.10 | −25.09 |
| Capex | 0.00 | 0.00 | 0.73 | 0.00 | 1.77 | 0.22 |
| Free cash flow | 0.00 | — | −0.99 | 3.99 | −32.91 | −24.94 |
| CFO / OP % | −357.0% | — | 2.0% | 36.0% | −119.0% | −130.0% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor days | 59 | 115 | 53 | 68 | 59 | 130 |
| Inventory days | 22 | 26 | 77 | 62 | 67 | 99 |
| Days payable | 41 | 39 | 7 | 40 | 4 | 2 |
| Cash conversion cycle | 39 | 101 | 121 | 89 | 121 | 226 |
| Working capital days | 33 | 77 | 88 | 77 | 111 | 214 |
| ROCE % | — | 133.0% | 27.0% | 34.0% | 35.0% | 15.0% |
For the Mar 2026 quarter, Nirman Agri Genetics reported sales of ₹49.93 Cr, down 59.7% year on year and net profit of ₹2.99 Cr, down 78.6% year on year. The operating margin was 7.0%.
Nirman Agri Genetics' sales for the year to Mar 2026 were ₹197 Cr.
Net profit for the year to Mar 2026 was ₹17.96 Cr. Earnings per share over the same trailing period were ₹22.06.
Nirman Agri Genetics reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹0.99 Cr.
Cash from operations was −₹23.90 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹24.94 Cr.